Literature DB >> 19160214

Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood.

Angela A Huertas-Ceballos1, Stuart Logan, Cathy Bennett, Colin Macarthur.   

Abstract

BACKGROUND: Between 4% and 25% of school-age children complain of recurrent abdominal pain (RAP) of sufficient severity to interfere with daily activities. It is unclear whether the diagnosis includes children with different aetiologies for their pain. For the majority no organic cause for their pain can be found on physical examination or investigation. Although most children are likely managed by reassurance and simple measures, a large range of interventions have been recommended.
OBJECTIVES: To determine the effectiveness of dietary interventions for recurrent abdominal pain in school-age children. SEARCH STRATEGY: The Cochrane Library (CENTRAL) 2006 (Issue 4), MEDLINE (1966 to Dec 2006), EMBASE (1980 to Dec 2006), CINAHL (1982 to Dec 2007), ERIC (1966 to Dec 2006), PsycINFO (1872 to Dec 2006), LILACS (1982 to Dec 2006), SIGLE (1980 to March 2005), and JICST (1985 to 06/2000) were searched . Where appropriate, search filters were employed. Researchers working in this area were asked to identify relevant studies. SELECTION CRITERIA: Randomised or quasi-randomised studies of any dietary treatment versus placebo or no treatment in school-age children with a diagnosis of RAP or functional gastrointestinal disorder based on the Rome II criteria. DATA COLLECTION AND ANALYSIS: Two authors independently assessed trials for inclusion, assessed quality and extracted data. Where appropriate studies were pooled using a random effects meta-analysis. MAIN
RESULTS: Seven trials were included in this review. Two trials, including 83 participants, compared fibre supplements with placebo (Christensen 1982, Feldman 1985), with data from one study reported in two papers (Christensen 1982, Christensen 1986). The pooled odds ratio for improvement in the frequency of abdominal pain was 1.26 (0.25, 6.29). Two trials, including 90 participants (Lebenthal 1981, Dearlove 1983) compared lactose-containing with lactose-free diets. Neither reported data in a form which could be used in the meta-analysis and the former trial had a loss to follow-up of 45%. We were not able to obtain further data for either trial. Three trials (Bausserman 2005, Gavronska 2007, Young 1997) comparing supplementation with Lactobacillus with placebo met the inclusion criteria but only two (Bausserman 2005, Gavronska 2007), including a total of 168 children, provided analysable data. The pooled odds ratio for improvement of symptoms was 1.17 (95% CI 0.62, 2.21). AUTHORS'
CONCLUSIONS: There is a lack of high quality evidence on the effectiveness of dietary interventions. This review provides no evidence that fibre supplements, lactose free diets or lactobacillus supplementation are effective in the management of children with RAP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19160214     DOI: 10.1002/14651858.CD003019.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  17 in total

Review 1.  Pharmacological interventions for recurrent abdominal pain in childhood.

Authors:  Alice E Martin; Tamsin V Newlove-Delgado; Rebecca A Abbott; Alison Bethel; Joanna Thompson-Coon; Rebecca Whear; Stuart Logan
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

Review 2.  Recurrent abdominal pain in childhood.

Authors:  Philip Bufler; Martina Gross; Holm H Uhlig
Journal:  Dtsch Arztebl Int       Date:  2011-04-29       Impact factor: 5.594

Review 3.  Management of functional abdominal pain and irritable bowel syndrome in children and adolescents.

Authors:  Eric Chiou; Samuel Nurko
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-06       Impact factor: 3.869

4.  Screening for Psychosocial and Family Risk in Pediatric Gastrointestinal Disorders.

Authors:  Carin Cunningham; Elise Cho; Michele L Shaffer; Miranda C Bradford; Tonya Palermo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-12       Impact factor: 2.839

5.  Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.

Authors:  B P Chumpitazi; J L Cope; E B Hollister; C M Tsai; A R McMeans; R A Luna; J Versalovic; R J Shulman
Journal:  Aliment Pharmacol Ther       Date:  2015-06-24       Impact factor: 8.171

6.  Probiotic treatment of irritable bowel syndrome in children.

Authors:  U Martens; P Enck; E Zieseniss
Journal:  Ger Med Sci       Date:  2010-03-02

7.  Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: a randomized trial.

Authors:  Andrea Horvath; Piotr Dziechciarz; Hania Szajewska
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

8.  Child and parent perceived food-induced gastrointestinal symptoms and quality of life in children with functional gastrointestinal disorders.

Authors:  Michelle J Carlson; Carolyn E Moore; Cynthia M Tsai; Robert J Shulman; Bruno P Chumpitazi
Journal:  J Acad Nutr Diet       Date:  2013-12-19       Impact factor: 4.910

Review 9.  Non-pharmacological management of abdominal pain-related functional gastrointestinal disorders in children.

Authors:  Siba Prosad Paul; Dharamveer Basude
Journal:  World J Pediatr       Date:  2016-06-30       Impact factor: 2.764

Review 10.  Irritable bowel syndrome in children: pathogenesis, diagnosis and evidence-based treatment.

Authors:  Bhupinder Kaur Sandhu; Siba Prosad Paul
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.